New analysis from the IMPACT-TD Registry confirms tardive dyskinesia (TD) causes a significant burden for most individuals with concomitant mood disorders, impacting their lives regardless of ageThe d ...

Learn about dyskinesia, including its causes, symptoms, types, and available treatment options to help manage involuntary ...

Learn how Huntington’s disease affects mood, including depression, anxiety, apathy, and irritability, plus treatment options and strategies for symptom management.

Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label medications, and lifestyle strategies to manage involuntary movements.

Correspondence to Dr Tamsin Newlove-Delgado, Children and Young People's Mental Health (ChYMe) research collaboration, University of Exeter Medical School, Exeter EX1 2LU, UK; ...

Medically reviewed by Huma Sheikh, MD Key Takeaways The medications approved by the Food and Drug Administration (FDA) for ...

Medically reviewed by Smita Patel, DOKey TakeawaysHuntington’s disease causes unintentional movements, as well as difficulty ...

Symptoms generally appear between the ages of 30 and 50 years and worsen over a 10- to 25-year period. Most people with HD experience chorea, an abnormal involuntary movement disorder, characterized ...

SAN DIEGO, Oct. 6, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented new data from the open-label KINECT ®-HD2 study demonstrating an established long-term safety ...